Description of Bogotá Birth Defects Surveillance and Follow-up Program

Insights

The Bogotá Congenital Malformations Surveillance Program (BCMSP) monitors birth defects, collecting data from public health systems and hospitals. This surveillance is crucial for evaluating interventions aimed at reducing child mortality and disabilities.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatrics

Background:

  • Congenital anomalies are a significant cause of child mortality and disability globally.
  • Effective interventions require robust epidemiologic surveillance systems.
  • Accurate monitoring of congenital anomalies in Bogotá, Colombia, has faced implementation challenges.

Purpose of the Study:

  • To describe the methodology of the Bogotá Congenital Malformations Surveillance Program (BCMSP).
  • To present key results from the BCMSP's monitoring efforts.
  • To provide data for evaluating strategies to reduce congenital anomalies.

Main Methods:

  • The BCMSP utilizes data from two primary sources: the National Public Health Surveillance System (SIVIGILA) and hospital case/control logs.
  • Methodology is aligned with the National Health Institute's standards.
  • Data collection has been ongoing since the establishment of the Secretaría Distrital de Salud in 2006.

Main Results:

  • BCMSP has monitored 431,670 births since its inception.
  • A total of 9,724 congenital malformations were identified.
  • Congenital malformations represent approximately 2% of the monitored births.

Conclusions:

  • The BCMSP provides essential data on congenital malformations in Bogotá.
  • The program's methodology allows for the tracking of birth defects.
  • Findings support the ongoing need for surveillance to inform public health strategies.

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
728
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.2K